| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 13,532 | 14,069 | 14,858 | 15,140 | | Cost of Revenue | 3,910 | 4,152 | 4,918 | 4,877 | | | Gross Profit | 9,622 | 9,917 | 9,940 | 10,263 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,187 | 7,127 | 6,586 | 7,534 | | Non Recurring | 3,664 | 5,613 | 5,992 |
-
| | Others | 5,719 | 4,278 | 2,730 | 463 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,948) | (7,101) | (5,368) | 2,266 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (6,948) | (7,101) | (5,368) | 2,266 | | Interest Expense | 1,536 | 1,508 | 1,553 | 1,669 | | Income Before Tax | (8,484) | (8,609) | (6,921) | 597 | | Income Tax Expense | 1,538 | (1,585) | (509) | (53) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,022) | (7,024) | (6,412) | 650 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,022) | (7,024) | (6,412) | 650 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,022) | ($7,024) | ($6,412) | $650 |
|
0.49% Nasdaq 
Income Statement
